Research Analysts Offer Predictions for Cibus Q1 Earnings

Cibus, Inc. (NASDAQ:CBUS - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings estimates for Cibus in a report released on Friday, March 21st. HC Wainwright analyst A. Dayal forecasts that the company will earn ($0.66) per share for the quarter. HC Wainwright has a "Buy" rating and a $25.00 price target on the stock. The consensus estimate for Cibus' current full-year earnings is ($2.96) per share. HC Wainwright also issued estimates for Cibus' Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.

Cibus (NASDAQ:CBUS - Get Free Report) last posted its earnings results on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing analysts' consensus estimates of ($0.68) by ($0.19). The business had revenue of $1.21 million for the quarter, compared to analyst estimates of $1.13 million. Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%.

Separately, Canaccord Genuity Group cut their price target on shares of Cibus from $20.00 to $18.00 and set a "buy" rating for the company in a report on Wednesday, January 22nd.

Cibus Stock Up 3.0 %

Shares of Cibus stock traded up $0.06 on Monday, reaching $2.04. The company's stock had a trading volume of 90,127 shares, compared to its average volume of 166,673. The company has a market capitalization of $53.97 million, a P/E ratio of -0.09 and a beta of 2.04. The stock has a 50-day moving average price of $2.31 and a 200-day moving average price of $3.27. Cibus has a 52-week low of $1.80 and a 52-week high of $22.99.

Remove Ads

Hedge Funds Weigh In On Cibus

Hedge funds and other institutional investors have recently made changes to their positions in the company. IFP Advisors Inc acquired a new position in Cibus in the 4th quarter valued at $36,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Cibus in the third quarter valued at about $44,000. Virtu Financial LLC purchased a new position in shares of Cibus in the third quarter worth about $48,000. Sei Investments Co. purchased a new position in shares of Cibus in the fourth quarter worth about $49,000. Finally, HighTower Advisors LLC grew its stake in Cibus by 20.6% during the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company's stock valued at $52,000 after acquiring an additional 2,750 shares in the last quarter. Hedge funds and other institutional investors own 33.81% of the company's stock.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.